APA (7th ed.) Citation

FS, L. F., H, T., K, A., SW, R., JY, M., HK, K., . . . DD, S. (2021). Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM). American journal of respiratory and critical care medicine, 204(10), 1143. https://doi.org/10.1164/rccm.202102-0289OC

Chicago Style (17th ed.) Citation

FS, Leitao Filho, et al. "Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM)." American Journal of Respiratory and Critical Care Medicine 204, no. 10 (2021): 1143. https://doi.org/10.1164/rccm.202102-0289OC.

MLA (9th ed.) Citation

FS, Leitao Filho, et al. "Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM)." American Journal of Respiratory and Critical Care Medicine, vol. 204, no. 10, 2021, p. 1143, https://doi.org/10.1164/rccm.202102-0289OC.